First Time Loading...

BioDelivery Sciences International Inc
NASDAQ:BDSI

Watchlist Manager
BioDelivery Sciences International Inc Logo
BioDelivery Sciences International Inc
NASDAQ:BDSI
Watchlist
Price: 5.59 USD -0.09%
Updated: May 8, 2024

Wall Street
Price Targets

BDSI Price Targets Summary
BioDelivery Sciences International Inc

There are no price targets for BDSI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioDelivery Sciences International Inc Competitors:
Price Targets
VRNO
Verano Holdings Corp
149% Upside
600572
Zhejiang CONBA Pharmaceutical Co Ltd
8% Upside
ABBOTINDIA
Abbott India Ltd
13% Upside
IPCALAB
IPCA Laboratories Ltd
11% Downside
PRPH
Prophase Labs Inc
297% Upside
ALKEM
Alkem Laboratories Ltd
4% Downside
300086
Honz Pharmaceutical Co Ltd
368% Upside
LAURUSLABS
Laurus Labs Ltd
11% Downside

Revenue
Forecast

Revenue Estimate
BioDelivery Sciences International Inc

For the last 8 years the compound annual growth rate for BioDelivery Sciences International Inc's revenue is 40%. The projected CAGR for the next 2 years is 23%.

40%
Past Growth
23%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
BioDelivery Sciences International Inc

Operating Income forecast
is not available for
BioDelivery Sciences International Inc

Net Income
Forecast

Net Income Estimate
BioDelivery Sciences International Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BDSI's stock price target?
Not Available

BDSI doesn't have any price targets made by Wall Street professionals.

What is BioDelivery Sciences International Inc's Revenue forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for BioDelivery Sciences International Inc's revenue is 40%. The projected CAGR for the next 2 years is 23%.